Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Valsartan Recall – Update
September 13, 2018 - The FDA announced an update to the ongoing investigation surrounding the recent voluntary recall of several drug products containing the active pharmaceutical ingredient (API) valsartan.
